Boothbay Fund Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-80,543
| Closed | -$304K | – | 1206 |
|
|
2024
Q4 | $304K | Sell |
80,543
-4,934
| -6% | -$18.7K | 0.01% | 911 |
|
|
2024
Q3 | $277K | Hold |
85,477
| – | – | 0.01% | 1102 |
|
|
2024
Q2 | $162K | Sell |
85,477
-17,300
| -17% | -$32.9K | ﹤0.01% | 1159 |
|
|
2024
Q1 | $292K | Sell |
102,777
-116,564
| -53% | -$331K | 0.01% | 1040 |
|
|
2023
Q4 | $3.23M | Buy |
+219,341
| New | +$3.23M | 0.08% | 277 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1498 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1548 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 1854 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 1722 |
|
|
2022
Q3 | – | Sell |
-34,500
| Closed | -$664K | – | 1927 |
|
|
2022
Q2 | $664K | Sell |
34,500
-13,771
| -29% | -$265K | 0.02% | 896 |
|
|
2022
Q1 | $620K | Buy |
+48,271
| New | +$620K | 0.01% | 932 |
|